Analgesics (Pharmacies) - Namibia

  • Namibia
  • Revenue in the Analgesics market is projected to reach US$2.75m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.88%, resulting in a market volume of US$3.49m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.04 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Namibia has been experiencing significant growth in recent years.

Customer preferences:
Customers in Namibia have shown a growing preference for analgesics purchased from pharmacies. This is due to the trust and reliability associated with purchasing medication from a licensed pharmacy. Customers value the convenience of being able to consult with a pharmacist and receive professional advice on the appropriate analgesic for their specific needs. Additionally, customers appreciate the wide range of analgesic options available in pharmacies, allowing them to choose the product that best suits their preferences and requirements.

Trends in the market:
One of the key trends in the Analgesics (Pharmacies) market in Namibia is the increasing demand for over-the-counter (OTC) analgesics. This can be attributed to several factors. Firstly, the growing awareness and acceptance of self-medication among consumers has led to a higher demand for OTC analgesics. Consumers are becoming more knowledgeable about common ailments and are confident in their ability to choose and use analgesics without a prescription. Secondly, the affordability and accessibility of OTC analgesics have contributed to their popularity. These products are often priced lower than prescription analgesics and can be easily purchased from pharmacies without the need for a doctor's visit.

Local special circumstances:
Namibia has a relatively small population compared to other countries, which has led to a concentrated market for analgesics. This means that the demand for analgesics is largely driven by the needs of the local population, rather than tourists or foreign visitors. The local market dynamics and preferences play a significant role in shaping the development of the Analgesics (Pharmacies) market in Namibia.

Underlying macroeconomic factors:
The growth of the Analgesics (Pharmacies) market in Namibia can also be attributed to several underlying macroeconomic factors. Firstly, the overall economic development of the country has led to an increase in disposable income, allowing consumers to spend more on healthcare products, including analgesics. Secondly, the improving healthcare infrastructure in Namibia has contributed to the growth of the market. The availability of well-equipped pharmacies and a trained workforce of pharmacists has made it easier for consumers to access analgesics and receive professional advice. Lastly, the increasing urbanization and changing lifestyles in Namibia have resulted in a higher incidence of health issues, such as stress and musculoskeletal problems, leading to a greater demand for analgesics. In conclusion, the Analgesics (Pharmacies) market in Namibia is developing due to the preferences of customers for purchasing medication from pharmacies, the increasing demand for OTC analgesics, the unique local market circumstances, and the underlying macroeconomic factors.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)